Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia

Ozone Therapy for Patients With COVID-19 Pneumonia: Preliminary Report of a Prospective Case-control Study

The objective is to determine whether the use of ozone autohemotherapy is associated with a decrease in time to clinical improvement

Inclusion Criteria:

• confirmed COVID-19 infection (diagnosed by nasopharyngeal swab performed on admission)
• severe pneumonia with baseline chest X-ray abnormalities;
• Oxygen saturation <94% on room air, and tachypnea with respiratory rate exceeding 30 per minute.
• Informed consent signed.

Exclusion Criteria:

• Not willing to participate in the study.